![Jasbir Seehra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jasbir Seehra
Vorstandsvorsitzender bei
KEROS THERAPEUTICS, INC.
Vermögen: 5 Mio $ am 31.05.2026
Profil
Jasbir S.
Seehra was the founder of Acceleron Pharma, Inc., founded in 2004, where the title held was Chief Scientific Officer & Senior Vice President from 2004 to 2010.
The current job is President, Chief Executive Officer & Director at Keros Therapeutics, Inc., starting in 2015 and continuing.
Former jobs include Independent Director at Eloxx Pharmaceuticals, Inc. from 2018 to 2022; Vice President at Wyeth LLC; Principal at Genetics Institute LLC; Principal at AVEO Pharmaceuticals, Inc.; Chief Scientific Officer at Ember Therapeutics, Inc. from 2011 to 2015; and Vice President-Biological Chemistry at Wyeth Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from The University of Southampton.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.04.2026 | 440’708 ( 2.23% ) | 5 Mio $ | 31.05.2026 |
Aktive Positionen von Jasbir Seehra
| Unternehmen | Position | Beginn |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.12.2015 |
Ehemalige bekannte Positionen von Jasbir Seehra
| Unternehmen | Position | Ende |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 28.06.2022 |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2015 |
| ACCELERON PHARMA INC. | Gründer | 01.11.2010 |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
| AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Jasbir Seehra
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Health Technology |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
